Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | ALPL | P05186 | 1/20 | 0.33 |
| ▸ | ALPG | P10696 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL28414129 | 0.98 | GAA (0.37) | GAACYP3A4MAPTTSHRL3MBTL1 | |
| SCHEMBL11388555 | 0.81 | MMP1 (0.32) | POLB | |
| SCHEMBL17160620 | 0.76 | SYK (0.32) | — | |
| SCHEMBL9732070 | 0.76 | POLB (0.32) | POLB | |
| SCHEMBL133836 | 0.75 | POLB (0.39) | POLB | |
| SCHEMBL8908315 | 0.75 | POLB (0.34) | POLB | |
| SCHEMBL11642326 | 0.73 | POLB (0.38) | POLB | |
| SCHEMBL7450031 | 0.73 | AKR1B1 (0.35) | TSHRKDM4ELMNAPOLBNPSR1 | |
| SCHEMBL18106811 | 0.72 | GAA (0.40) | GAACYP3A4MAPTTSHRL3MBTL1 | |
| SCHEMBL11826548 | 0.72 | GAA (0.40) | GAACYP3A4MAPTTSHRL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260013649-A1 | BEDDING COMPONENTS INCLUDING FLUID ABSORBING GEL BEADS | YOUNGBLOOD IP HOLDINGS, LLC (US) | 2026-01-15 | — | — | US | disclosed |
| US-20250295244-A1 | BEDDING COMPONENTS INCLUDING FLUID ABSORBING GEL BEADS | YOUNGBLOOD IP HOLDINGS, LLC (US) | 2025-09-25 | — | — | US | disclosed |
| US-20250295245-A1 | BEDDING COMPONENTS INCLUDING FLUID ABSORBING GEL BEADS | YOUNGBLOOD IP HOLDINGS, LLC (US) | 2025-09-25 | — | — | US | disclosed |
| US-12419435-B1 | Bedding components including fluid absorbing gel beads | YOUNGBLOOD IP HOLDINGS, LLC (US) | 2025-09-23 | — | — | US | disclosed |
| CN-120059162-A | Polyether amine type hydantoin bonding agent, preparation method and application thereof | 湖北航天化学技术研究所 | 2025-05-30 | — | — | CN | disclosed |
| US-12070130-B1 | Bedding components including fluid absorbing gel beads | YOUNGBLOOD IP HOLDINGS, LLC (US) | 2024-08-27 | — | — | US | disclosed |
| US-20240208946-A1 | FUNCTIONALIZED MATERIALS AND COMPOUNDS | UNIVERSITY OF SOUTH ALABAMA (US) | 2024-06-27 | — | — | US | disclosed |
| US-12006309-B2 | Functionalized materials and compounds | UNIVERSITY OF SOUTH ALABAMA (US) | 2024-06-11 | — | — | US | disclosed |
| US-20230259028-A1 | RESIST UNDERLAYER FILM-FORMING COMPOSITION CONTAINING REACTION PRODUCT OF HYDANTOIN COMPOUNDS | NISSAN CHEMICAL CORPORATION (JP) | 2023-08-17 | — | — | US | disclosed |
| CN-111979767-B | Method for preparing halamine antibacterial cotton fabric by adopting ultraviolet light grafting technology | 盐城工学院 | 2023-01-31 | — | — | CN | disclosed |
| US-20220081424-A1 | FUNCTIONALIZED MATERIALS AND COMPOUNDS | UNIVERSITY OF SOUTH ALABAMA (US) | 2022-03-17 | — | — | US | disclosed |
| US-11192883-B2 | Functionalized materials and compounds | UNIVERSITY OF SOUTH ALABAMA (US) | 2021-12-07 | — | — | US | disclosed |
| US-20210309643-A1 | FUNCTIONALIZED MATERIALS AND COMPOUNDS | UNIVERSITY OF SOUTH ALABAMA (US) | 2021-10-07 | — | — | US | disclosed |
| CN-112755651-A | Multi-combination functional electrostatic spinning submicron fiber air filter material and preparation thereof | 东华大学 | 2021-05-07 | — | — | CN | disclosed |
| US-10858344-B2 | Hydantoin containing deoxyuridine triphosphatase inhibitors | CV6 THERAPEUTICS (NI) LIMITED (GB) | 2020-12-08 | — | — | US | disclosed |
| US-10858344-B2 | Hydantoin containing deoxyuridine triphosphatase inhibitors | CV6 THERAPEUTICS (NI) LIMITED (GB) | 2020-12-08 | — | — | US | disclosed |
| CN-108043233-B | Oxidation-resistant polyamide reverse osmosis membrane and preparation method and application thereof | 万华化学集团股份有限公司 | 2020-09-08 | — | — | CN | disclosed |
| WO-2018098206-A1 | HYDANTOIN CONTAINING DEOXYURIDINE TRIPHOSPHATASE INHIBITORS | CV6 THERAPEUTICS (NI) LIMITED (GB) | 2018-05-31 | — | — | WO | disclosed |
| EP-1001930-A2 | N-HYDROXYFORMAMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES | Abbott Laboratories (US) | 2000-05-24 | — | — | EP | disclosed |
| WO-1999006361-A2 | N-HYDROXYFORMAMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES | ABBOTT LABORATORIES (US) | 1999-02-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10858344-B2 | Hydantoin containing deoxyuridine triphosphatase inhibitors | DUT, TYMP, DPYD | GAA 347/4885CYP3A4 3304/4885MAPT 3695/4885 |
| US-12006309-B2 | Functionalized materials and compounds | MGMT, VCL, ALG1 | GAA 710/4885CYP3A4 677/4885MAPT 2176/4885 |
| US-11192883-B2 | Functionalized materials and compounds | MGMT, VCL, ALK | GAA 548/4885CYP3A4 864/4885MAPT 1869/4885 |
| US-20210309643-A1 | FUNCTIONALIZED MATERIALS AND COMPOUNDS | MGMT, VCL, ALK | GAA 548/4885CYP3A4 864/4885MAPT 1869/4885 |
| US-20260013649-A1 | BEDDING COMPONENTS INCLUDING FLUID ABSORBING GEL BEADS | ARG1, SLC14A1, ASS1 | GAA 3595/4885CYP3A4 4184/4885MAPT 567/4885 |
| US-20220081424-A1 | FUNCTIONALIZED MATERIALS AND COMPOUNDS | MGMT, VCL, ALG1 | GAA 710/4885CYP3A4 677/4885MAPT 2176/4885 |
| US-20240208946-A1 | FUNCTIONALIZED MATERIALS AND COMPOUNDS | MGMT, VCL, ALG1 | GAA 710/4885CYP3A4 677/4885MAPT 2176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.